UFP Technologies, Inc. announced record first-quarter results for 2025, with net income rising to $17.2 million and diluted EPS reaching $2.21. Net sales increased to $148.1 million, up from $105.0 million in the prior year, primarily due to strong growth in the MedTech business.
Net income increased 35.4% to $17.2 million in Q1 2025.
Diluted EPS rose to $2.21 in Q1 2025, up from $1.64 in Q1 2024.
Net Sales for Q1 2025 were $148.1 million, a 41.1% increase from Q1 2024.
MedTech business grew 50%, driven by strong demand in Safe Patient Handling.
UFP Technologies anticipates continued growth, particularly in its MedTech business, supported by strategic expansions, new manufacturing agreements, and ongoing acquisition efforts. The company expects significant revenue generation from new robotic surgery programs in 2026 and beyond.
Analyze how earnings announcements historically affect stock price performance